Skip to main content
. 2016 Apr 7;2016:6830713. doi: 10.1155/2016/6830713

Table 4.

Odds ratio (OR) and 95% confidence interval (CI) of detection of various colorectal neoplasm using colonoscopy as a gold standard by different positive combinations of double fecal immunochemical tests (FITs) in the Jiashan mass colorectal cancer (CRC) screening program in China, 2007–2009.

FIT1 FIT2 FITs Positive Colonoscopy Results: n, detection rate, percentagea
n n n CRC Advanced adenoma Nonadvanced adenoma Advanced neoplasm
+ 20,842 763 619 12, 1.9, 30.1 37, 6.0, 42.0 49, 7.9, 39.8 49, 7.9, 38.6
+ + 20,842 301 250 18, 7.2, 46.2 30, 12.0, 34.1 24, 9.6, 19.5 48, 19.2, 37.8
+ Absent 3,533 84 57 3, 5.3, 7.7 3, 5.3, 3.4 5, 8.8, 4.1 6, 7.1, 4.7
+ 20,842 609 500 6, 1.2, 15.4 18, 3.6, 20.5 44, 8.8, 35.8 24, 4.8, 18.9
Absent + 44 5 4 0 0 1, 25.0, 0.5 0
FIT1+b 24375 1,148 926 33, 3.6, 84.6 70, 7.6, 79.5 78, 8.4, 63.4 103, 11.1, 81.1
FIT2+c 20886 915 754 24, 3.2, 61.5 48, 6.4, 54.5 69, 9.2, 56.1 72, 9.5, 56.7
Total 24,419 1,762 1,430 39, 2.7, 100.0 88, 6.2, 100.0 123, 8.6, 100.0 127, 8.9, 100.0
OR (95% CI) of detection rate by FIT (FIT2 versus FIT1) 0.85 (0.50–1.44) 0.80 (0.55–1.16) 1.03 (0.75–1.43) 0.82 (0.60–1.10)
OR (95% CI ) of detection rate by FIT (FITs versus FIT1) 1.18 (0.74–1.88) 1.26 (0.92–1.72) 1.58 (1.19–2.10) 1.38 (1.07–1.80)

FIT1, the first FIT; FIT2, the second FIT; FITs, combination of FIT1 and FIT2.

aDetection rate: the number of the colorectal lesions/the number of participants who completed colonoscopy in any combination of FIT1 and FIT2; percentage: the number of the colorectal lesions/the total number of the colorectal lesions in any combination of FIT1 and FIT2.

bReferred to those who completed FIT1 regardless of the completion of FIT2.

cReferred to those who completed FIT2 regardless of the completion of FIT1.